台股 » 個股 » 中裕 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

中裕

(4147)
可現股當沖
  • 股價
    77.8
  • 漲跌
    ▼1.1
  • 漲幅
    -1.39%
  • 成交量
    475
  • 產業
    上櫃 生技醫療類股
  • 321人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
中裕 (4147)籌碼相關-華南永昌-古亭 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw06/0806/2207/0607/2208/0208/1608/3009/1409/2810/1210/2611/0811/2212/0612/2001/0401/1802/0802/2203/0803/1803/2804/1004/2004/3005/1205/1460708090100110Jul '24Sep '24Nov '24Mar '25May '2560d90dAll

華南永昌-古亭 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/05/12578.8000.0078.9051,8480.27%
2025/05/06580.1800.0080.2051,8730.27%
2025/04/3000.002782.2281.80-271,875-1.44%
2025/04/2500.00581.0080.00-51,873-0.27%
2025/04/247279.3300.0079.60721,8793.83%
2025/04/21576.5000.0075.3051,8940.26%
2025/04/1500.00578.5077.80-52,347-0.21%
2025/04/142076.002576.9177.20-52,375-0.21%
2025/04/111171.301671.3073.80-52,377-0.21%
2025/04/0900.00167.4066.80-12,377-0.04%
2025/04/08371.304071.5571.30-372,331-1.59%
2025/04/02288.9500.0087.9022,2940.09%
2025/03/31290.10188.7088.0012,2770.04%
2025/03/28294.20193.8093.8012,2570.04%
2025/03/26098.00599.1098.10-52,230-0.22%
2025/03/243697.943498.5699.0022,1920.09%
2025/03/21196.1000.0096.4012,1490.05%
2025/03/2000.00394.1095.80-32,123-0.14%
2025/03/19193.1000.0092.8012,0980.05%
2025/03/1700.00092.4091.9002,0770.00%
2025/03/13394.1000.0091.6032,0990.14%
2025/03/0700.00397.3396.50-31,991-0.15%
2025/03/06195.6000.0094.3011,9570.05%
2025/03/0500.001897.4798.60-181,924-0.94%
2025/03/04292.0500.0095.5021,9040.11%
2025/03/031195.3600.0094.20111,8870.58%
2025/02/27195.5000.0095.5011,8780.05%
2025/02/261298.0915100.1798.00-31,886-0.16%
2025/02/2567100.0915101.0099.30521,8562.80%
2025/02/2415100.0015101.0099.3001,7960.00%
2025/02/2146101.1046104.2598.9001,7270.00%
2025/02/20197.604197.7999.70-401,553-2.58%
2025/02/1900.005.195.9895.20-5.11,510-0.34%
2025/02/18194.4900.0094.0011,4910.07%
2025/02/17102.1101.9473106.9497.1029.11,4402.02% 大買/
2025/02/142499.94398.9098.90211,2261.71%
2025/02/1100.00491.8091.70-41,140-0.35%
2025/02/0700.00089.0090.1001,1250.00%
2025/02/06087.1000.0087.8001,1150.00%
2025/02/04485.8500.0083.3041,1140.36%
2025/01/13389.20391.0089.9001,1320.00%
2025/01/10187.70389.2390.50-21,064-0.19%
2025/01/09388.60187.5087.5021,0140.20%
2025/01/081101.0011101.2797.20-10872-1.15%
2025/01/0600.00190.5089.80-1611-0.16%
2025/01/032088.5200.0088.30206003.33%
2024/12/1700.001081.3482.00-10625-1.60%
2024/12/1100.00386.7786.00-3621-0.48%
2024/12/10588.08687.3087.50-1615-0.16%
2024/12/09187.90388.8790.10-2600-0.33%
2024/12/0630388.967189.2287.6023257340.47% 大買/鉅額交易
2024/12/058185.522185.8085.006052711.36%
2024/12/045784.591984.8085.30385297.18%
2024/12/0317185.415985.6684.3011252921.16% 大買/鉅額交易
2024/12/024785.2700.0084.20475248.96%
2024/11/29284.1000.0084.3025240.38%
2024/11/28381.8000.0082.0035340.56%
2024/11/2500.00584.9085.00-5543-0.92%
2024/11/2200.00580.1079.90-5512-0.98%
2024/11/0800.0032.280.6580.10-32.2522-6.17%
2024/10/2100.00175.2075.10-1559-0.18%
2024/10/09174.5000.0073.9016220.16%
2024/09/3000.004080.0179.70-40642-6.23%
2024/09/2700.006580.2180.10-65649-10.01%
2024/09/2600.004181.5380.20-41650-6.30%
2024/09/2400.00180.5081.10-1640-0.16%
2024/09/1300.001079.7179.30-10672-1.49%
2024/09/0300.001083.7084.00-10751-1.33%
2024/09/021086.3000.0085.30107531.33%
2024/08/271082.0000.0082.00107391.35%
2024/08/0500.001575.8974.00-15734-2.04%
2024/07/29183.7000.0082.6017410.13%
2024/07/19288.8000.0086.5027270.27%
2024/07/10484.9000.0085.8047830.51%
2024/07/04286.9500.0086.9028890.22%
2024/07/03588.0400.0087.4059530.52%
2024/07/02189.8000.0088.6019920.10%
2024/07/01190.1000.0090.2011,0960.09%
2024/06/28489.6500.0089.3041,1030.36%
2024/06/2600.00189.3089.50-11,123-0.09%
2024/06/25186.4000.0087.8011,1210.09%
2024/06/0600.00190.0089.40-11,196-0.08%
2024/06/05190.3000.0090.3011,2370.08%
2024/05/2000.00287.3087.20-22,130-0.09%
中裕首度與美國客戶簽訂CDMO合約 營運添動能Anue鉅亨-12天前
〈美對等關稅〉中裕回應暫無影響 愛滋病新藥足以供應美國市場銷售Anue鉅亨-2025/04/09
中裕長效愛滋療法主要指標達標 啟動國際授權合作Anue鉅亨-2025/03/26
中裕 相關文章